Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106273757 | 10627375 | 7 | F | 201404 | 20160810 | 20141204 | 20160818 | EXP | CA-ROCHE-1501878 | ROCHE | 33.76 | YR | F | Y | 0.00000 | 20160818 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106273757 | 10627375 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 103976 | 300 | MG | SOLUTION FOR INJECTION | QOW | |||||||
| 106273757 | 10627375 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 103976 | 300 | MG | SOLUTION FOR INJECTION | QOW | |||||||
| 106273757 | 10627375 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||||
| 106273757 | 10627375 | 4 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 106273757 | 10627375 | 5 | C | FLOVENT | FLUTICASONE PROPIONATE | 1 | Unknown | U | 0 | ||||||||||
| 106273757 | 10627375 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
| 106273757 | 10627375 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106273757 | 10627375 | 1 | Asthma |
| 106273757 | 10627375 | 4 | Product used for unknown indication |
| 106273757 | 10627375 | 5 | Product used for unknown indication |
| 106273757 | 10627375 | 6 | Product used for unknown indication |
| 106273757 | 10627375 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106273757 | 10627375 | OT |
| 106273757 | 10627375 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106273757 | 10627375 | Asthma | |
| 106273757 | 10627375 | Cough | |
| 106273757 | 10627375 | Dysphagia | |
| 106273757 | 10627375 | Forced expiratory volume decreased | |
| 106273757 | 10627375 | Malaise | |
| 106273757 | 10627375 | Post procedural complication | |
| 106273757 | 10627375 | Pyrexia | |
| 106273757 | 10627375 | Red blood cell count decreased | |
| 106273757 | 10627375 | Sinusitis | |
| 106273757 | 10627375 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106273757 | 10627375 | 1 | 20131122 | 0 | ||
| 106273757 | 10627375 | 2 | 20150116 | 20150116 | 0 |